| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 96.37× | 96.37× | 83.74× | 84.86× | 85.89× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.54× | 1.53× | 2.17× | 2.12× | 2.26× | ||
| 1.18× | 1.18× | 1.42× | 1.49× | 1.43× | ||
| 0.83× | 0.83× | 0.84× | 0.82× | 0.61× | ||
| 0.69× | 0.69× | 0.68× | 0.69× | 0.47× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 85.89 | 84.86 | 83.74 | 96.37 | 96.37 | |
| Working Capital Turnover | 2.26 | 2.12 | 2.17 | 1.53 | 1.54 | |
| Asset Turnover | 1.43 | 1.49 | 1.42 | 1.18 | 1.18 | |
| Cash Conversion (CFO/Net Income) | 0.61 | 0.82 | 0.84 | 0.83 | 0.83 | |
| CFO/EBITDA | 0.47 | 0.69 | 0.68 | 0.69 | 0.69 |